Publications

5532 Results

Phase II trial of ifosfamide and cisplatin in the treatment of metastatic soft tissue sarcomas. A Southwest Oncology Group study.

Authors
GT Budd;B Metch;SAW Weiss;JK Weick;C Fabian;RL Stephens;SP Balcerzak
Journal / Conference
Cancer Chemotherapy and Pharmacology 31(Suppl.2):S213-S216
Year
1993
Research Committee(s)
Sarcoma

Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma: A Southwest Oncology Group study.

Authors
WH Harvey;TR Fleming;PJ Goodman;JE Harkins;SE Rivkin;JS Macdonald
Journal / Conference
IND 11:45-46
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8712

Phase II trial of amonafide in advanced colorectal cancer: A Southwest Oncology Group study.

Authors
TD Brown;PJ Goodman;T Fleming;JS Macdonald;JB Craig;AB Einstein
Journal / Conference
Anti-Cancer Drugs 4:49-50
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8714

Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma: A Southwest Oncology Group Study.

Authors
RM Bukowski;TR Fleming;JS Macdonald;N Oishi;SA Taylor;LH Baker
Journal / Conference
Cancer 71(2):322-325
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8040, SWOG-8044

Alternating combination chemotherapy in patients with extragonadal germ cell tumors: A Southwest Oncology Group study.

Authors
RM Bukowski;M Wolf;BG Kulander;J Montie;ED Crawford;B Blumenstein
Journal / Conference
Cancer 71(8):2631-2638
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8231

Doxorubicin, mitomycin C and 5-fluorouracil in the treatment of hormone refractory adenocarcinoma of the prostate: A Southwest Oncology Group study.

Authors
B Blumenstein;ED Crawford;JH Saiers;RL Stephens;SE Rivkin;MF Sarosdy;CA Coltman Jr;B Tranum;J Costanzi
Journal / Conference
Journal of Urology 150:411-413
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8302

Pitfalls in quality-of-life assessment: Lessons from a Southwest Oncology Group breast cancer clinical trial.

Authors
KA Hayden;CM Moinpour;B Metch;P Feigl;RM O'Bryan;S Green;CK Osborne
Journal / Conference
Oncology Nursing Forum 20(9):1415-1419
Year
1993
Research Committee(s)
Breast
Study Number(s)
SWOG-8313 (EST 5186)

Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study.

Authors
DS Alberts;S Dahlberg;SJ Green;D Garcia;EV Hannigan;R O'Toole;D Stock-Novack;EA Surwit;VK Malviya;CJ Jolles
Journal / Conference
Cancer 71(2):618-627
Year
1993
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: A Southwest Oncology Group study.

Authors
JW Goodwin;J Crowley;HJ Eyre;B Stafford;KA Jaeckle;JJ Townsend
Journal / Conference
Journal of Neuro-Oncology 15:75-77
Year
1993
Research Committee(s)
Brain
Study Number(s)
SWOG-8415

P-glycoprotein expression in human plasma cell myeloma: Correlation with prior chemotherapy.

Authors
TM Grogan;CM Spier;SE Salmon;M Matzner;JA Rybski;RS Weinstein;RJ Scheper;WS Dalton
Journal / Conference
Blood 81(2):490-495
Year
1993
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8624